Protalix BioTherapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Protalix BioTherapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update

Protalix BioTherapeutics (PLX) Reports Q3 Revenues Beat

October 29, 2020 7:50 AM EDT

Protalix BioTherapeutics (NYSE: PLX) reported Q3 revenue for the quarter came in at $10.8 million versus the consensus estimate of $10.08 million.

Third Quarter 2020 Financial Highlights

The Company recorded revenues from selling goods of $3.3 million during the three months ended September 30, 2020, a decrease of $1.8 million, or 36%, compared to revenues of $5.1 million for the same period of 2019. The decrease resulted primarily from a timing difference in sales to Brazil in 2020... More